Analyst Ratings for Genmab A/S (GMAB)
GMAB Rating Summary
GMAB Price Target Summary
- Highest: $50.00 (H.C. Wainwright)
- Lowest: $33.50 (Goldman Sachs)
- Average: $45.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$45.50 (+65.3%)
* Over Last 12-Mos
Rating Score: 2.5 / 10
Percentile Rank: 20%
Avg. $ Target:
$45.50 (+65.3%)
* Over Last 12-Mos
Rating Score: 2.5 / 10
Percentile Rank: 20%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/23/2024 | BMO Capital | Etzer Darout | Upgrade | Outperform (Market Perform) |
48.00 (46.00) |
29.11 (27.53) |
-5.43% | Details |
| 10/18/2023 | Exane BNP Paribas | Victor Floch | New Coverage | Underperform (N/A) |
N/A (N/A) |
31.92 (27.53) |
-13.75% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
